2025
SJR Q2
JCR Q2 · 3,5
756 eşleşen makale
SCIE
Dergi ayrıntısı
Archiv der Pharmazie
- Yayıncı
- Wiley-VCH Verlag
- Ülke
- Germany · Western Europe
- Tür
- journal
- ISSN
-
0365623315214184
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,527
- Quartile Q2
- H-Index 80
- Atıf/yayın 3,77
- Doküman (3y) 557
- Atıf (3y) 2.227
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,5
- 5Y JIF 4
- JCI 0,71
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Drug Discovery Q3
- Pharmaceutical Science Q2
Alanlar
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Chemistry, Medicinal | Chemistry, Multidisciplinary | Pharmacology & Pharmacy
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,527 | 3,5 | 4 | 0,71 | Q2 | 80 |
| 2024 | Q2 | Q2 | 0,571 | 3,6 | 4,2 | 0,85 | Q2 | 76 |
| 2023 | Q2 | Q1 | 0,642 | 4,3 | 4,4 | 0,99 | Q1 | 76 |
| 2022 | Q2 | Q1 | 0,549 | 5,1 | 4,2 | 0,99 | Q1 | 76 |
| 2021 | Q2 | Q2 | 0,536 | 4,6 | 3,7 | 0,89 | Q2 | 76 |
| 2020 | Q2 | Q2 | 0,468 | 3,8 | 2,9 | 0,84 | Q2 | 76 |
| 2019 | Q2 | Q2 | 0,366 | 2,6 | 2,2 | 0,69 | Q2 | 76 |
| 2018 | — | Q3 | — | 2,1 | 2,1 | 0,64 | Q2 | — |
| 2017 | Q2 | Q2 | 0,413 | 2,3 | 2 | 0,61 | Q2 | 76 |
| 2016 | Q2 | Q2 | 0,561 | 2 | 1,9 | — | — | 76 |
| 2015 | Q1 | Q2 | 0,63 | 2 | 2 | — | — | 76 |
| 2014 | Q2 | Q2 | 0,528 | 1,5 | 1,7 | — | — | 76 |
| 2013 | Q2 | Q2 | 0,522 | 1,4 | 1,7 | — | — | 76 |
| 2012 | Q2 | Q2 | 0,584 | 1,5 | 1,7 | — | — | 76 |
| 2011 | Q1 | Q2 | 0,599 | 1,7 | 1,8 | — | — | 76 |
| 2010 | Q1 | Q2 | 0,579 | 1,5 | 1,6 | — | — | 76 |
| 2009 | — | Q2 | — | 1,8 | 1,7 | — | — | — |
| 2008 | — | Q2 | — | 1,4 | 1,5 | — | — | — |
| 2007 | — | Q2 | — | 1,3 | 1,3 | — | — | — |
| 2006 | — | Q2 | — | 1,1 | — | — | — | — |
| 2005 | — | Q2 | — | 1,1 | — | — | — | — |
| 2004 | — | Q3 | — | 0,7 | — | — | — | — |
| 2003 | — | Q3 | — | 0,6 | — | — | — | — |
| 2002 | — | Q3 | — | 0,6 | — | — | — | — |
| 2001 | — | Q2 | — | 0,9 | — | — | — | — |
| 2000 | — | Q2 | — | 0,9 | — | — | — | — |
| 1999 | — | Q2 | — | 0,7 | — | — | — | — |
| 1998 | — | Q3 | — | 0,6 | — | — | — | — |
| 1997 | — | Q3 | — | 0,5 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 36/72 |
| 2025 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 114/250 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 134/356 |
| 2024 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 32/72 |
| 2024 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 96/239 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 103/352 |
| 2023 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 20/72 |
| 2023 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q1 | 72/231 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 69/354 |
| 2022 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 16/60 |
| 2022 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q1 | 59/178 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 56/278 |
| 2021 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 24/63 |
| 2021 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 69/179 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 89/279 |
| 2020 | CHEMISTRY, MEDICINAL | SCIE | Q2 | Q2 | 27/62 |
| 2020 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 73/178 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 123/276 |
| 2019 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 33/61 |
| 2019 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 86/177 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 148/271 |
| 2018 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 40/61 |
| 2018 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q2 | 91/172 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 170/267 |
| 2017 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 38/59 |
| 2017 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 81/171 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 149/261 |
| 2016 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 38/60 |
| 2016 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 81/166 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 163/257 |
| 2015 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 36/59 |
| 2015 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 71/163 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 151/255 |
| 2014 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 41/59 |
| 2014 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 75/157 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 180/255 |
| 2013 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 42/58 |
| 2013 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 74/148 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 180/256 |
| 2012 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 40/59 |
| 2012 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 69/152 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 178/261 |
| 2011 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 36/59 |
| 2011 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 60/154 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 167/261 |
| 2010 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 30/54 |
| 2010 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 59/147 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 175/252 |
| 2009 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 24/46 |
| 2009 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 48/140 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 151/237 |
| 2008 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 24/41 |
| 2008 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 56/127 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 156/219 |
| 2007 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 25/41 |
| 2007 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 54/128 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 145/205 |
| 2006 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 25/35 |
| 2006 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 60/124 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 153/199 |
| 2005 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 24/34 |
| 2005 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 51/125 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 144/193 |
| 2004 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 32/36 |
| 2004 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 74/125 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 161/187 |
| 2003 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 32/37 |
| 2003 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 75/123 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 160/185 |
| 2002 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 31/35 |
| 2002 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 70/119 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 156/188 |
| 2001 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 25/36 |
| 2001 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 48/118 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 130/186 |
| 2000 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 22/35 |
| 2000 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 46/118 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 120/181 |
| 1999 | CHEMISTRY | SCIE | Q2 | — | 59/121 |
| 1999 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 24/30 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 132/175 |
| 1998 | CHEMISTRY | SCIE | Q3 | — | 64/126 |
| 1998 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 23/30 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 128/178 |
| 1997 | CHEMISTRY | SCIE | Q3 | — | 73/111 |
| 1997 | CHEMISTRY, MEDICINAL | SCIE | Q4 | — | 23/28 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 130/157 |